Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
The Annals of Pharmacotherapy
|
December 16, 2017
Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy
Nathan D Seligson, Athena L V Hobbs, Joanna M Leonard, et al.
Cell Death Discovery
|
June 23, 2020
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives
Mir Mohd Faheem, Nathan D Seligson, Syed Mudabir Ahmad, et al.
The Annals of Pharmacotherapy
|
May 29, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a <i>KMT2A</i> Translocation
Emilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom, et al.
Molecular Carcinogenesis
|
May 3, 2023
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas
Ernest Duah, Nathan D Seligson, Avinash K Persaud, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 28, 2025
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health System
Megan L Miller, Nathan D Seligson, Benjamin Q Duong, et al.
Oncotarget
|
October 18, 2019
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
Nathan D Seligson, Colin W Stets, Bryce W Demoret, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
NPJ Precision Oncology
|
May 22, 2021
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target
Nathan D Seligson, Richard D Maradiaga, Colin M Stets, et al.
Molecular Oncology
|
March 13, 2025
Revisiting CDKN2A dysregulation in Ewing sarcoma
Anjali Paragji, Vivek Shastri, Elham Nasri, et al.
Pediatric Research
|
August 16, 2025
Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment
Benjamin Q Duong, Nathan D Seligson, Kelsey J Cook, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
The Annals of Pharmacotherapy
|
December 16, 2017
Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy
Nathan D Seligson, Athena L V Hobbs, Joanna M Leonard, et al.
Cell Death Discovery
|
June 23, 2020
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives
Mir Mohd Faheem, Nathan D Seligson, Syed Mudabir Ahmad, et al.
The Annals of Pharmacotherapy
|
May 29, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a <i>KMT2A</i> Translocation
Emilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom, et al.
Molecular Carcinogenesis
|
May 3, 2023
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas
Ernest Duah, Nathan D Seligson, Avinash K Persaud, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
July 28, 2025
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health System
Megan L Miller, Nathan D Seligson, Benjamin Q Duong, et al.
Oncotarget
|
October 18, 2019
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
Nathan D Seligson, Colin W Stets, Bryce W Demoret, et al.
Surgical Oncology
|
August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas
Nathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
NPJ Precision Oncology
|
May 22, 2021
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target
Nathan D Seligson, Richard D Maradiaga, Colin M Stets, et al.
Molecular Oncology
|
March 13, 2025
Revisiting CDKN2A dysregulation in Ewing sarcoma
Anjali Paragji, Vivek Shastri, Elham Nasri, et al.
Pediatric Research
|
August 16, 2025
Preferences for implementing pharmacogenomics in pediatric primary care: a discrete choice experiment
Benjamin Q Duong, Nathan D Seligson, Kelsey J Cook, et al.
Page
of 4